Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Meyronet

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Annals of Diagnostic Pathology|September 21, 2023
Carbon footprint evaluation of routine anatomic pathology practices using eco-audit: Current status and mitigation strategiesAlexis Trecourt, Pierre-Jean Cottinet, Marie Donzel, et al.
Acta Neuropathologica Communications|January 16, 2023
Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusionAlice Métais, Arnault Tauziède-Espariat, Jeremy Garcia, et al.
Nature Communications|January 23, 2023
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cellsSébastien Durand, Marion Bruelle, Fleur Bourdelais, et al.
The Lancet. Neurology|March 26, 2011
New lexicon and criteria for the diagnosis of Alzheimer's diseaseGiorgio Giaccone, Thomas Arzberger, Irina Alafuzoff, et al.
Annals of Clinical and Translational Neurology|January 12, 2025
Demyelinating neuropathy as the initial presentation of familial E200K Creutzfeldt-Jakob disease in two patientsCécile Delorme, Antoine Pégat, Julian Theuriet, et al.
Neuro-Oncology Advances|May 31, 2021
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adultsThiébaud Picart, Marc Barritault, Delphine Poncet, et al.
Neuro-Oncology Advances|June 10, 2024
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA NetworkInes Esparragosa Vazquez, Marc Sanson, Olivier L Chinot, et al.
Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patientsVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Frontiers in Oncology|December 5, 2022
Improved NGS-based detection of microsatellite instability using tumor-only dataAna Claudia Marques, Carole Ferraro-Peyret, Frederic Michaud, et al.
Journal of Clinical Microbiology|February 22, 2023
Fungal Integrated Histomolecular Diagnosis Using Targeted Next-Generation Sequencing on Formalin-Fixed Paraffin-Embedded TissuesAlexis Trecourt, Meja Rabodonirina, Claire Mauduit, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Annals of Diagnostic Pathology|September 21, 2023
Carbon footprint evaluation of routine anatomic pathology practices using eco-audit: Current status and mitigation strategiesAlexis Trecourt, Pierre-Jean Cottinet, Marie Donzel, et al.
Acta Neuropathologica Communications|January 16, 2023
Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusionAlice Métais, Arnault Tauziède-Espariat, Jeremy Garcia, et al.
Nature Communications|January 23, 2023
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cellsSébastien Durand, Marion Bruelle, Fleur Bourdelais, et al.
The Lancet. Neurology|March 26, 2011
New lexicon and criteria for the diagnosis of Alzheimer's diseaseGiorgio Giaccone, Thomas Arzberger, Irina Alafuzoff, et al.
Annals of Clinical and Translational Neurology|January 12, 2025
Demyelinating neuropathy as the initial presentation of familial E200K Creutzfeldt-Jakob disease in two patientsCécile Delorme, Antoine Pégat, Julian Theuriet, et al.
Neuro-Oncology Advances|May 31, 2021
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adultsThiébaud Picart, Marc Barritault, Delphine Poncet, et al.
Neuro-Oncology Advances|June 10, 2024
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA NetworkInes Esparragosa Vazquez, Marc Sanson, Olivier L Chinot, et al.
Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patientsVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Frontiers in Oncology|December 5, 2022
Improved NGS-based detection of microsatellite instability using tumor-only dataAna Claudia Marques, Carole Ferraro-Peyret, Frederic Michaud, et al.
Journal of Clinical Microbiology|February 22, 2023
Fungal Integrated Histomolecular Diagnosis Using Targeted Next-Generation Sequencing on Formalin-Fixed Paraffin-Embedded TissuesAlexis Trecourt, Meja Rabodonirina, Claire Mauduit, et al.
Pageof 14